Skip to main content
OpenTrials
Completed

NCT Number: NCT01739673

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infectious Keratitis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Schwartz Laser Eye Center, Scottsdale, Arizona, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects must be 18 years of age or older.
  • Ability to provide written informed consent.
  • Likely to complete all study visits.
  • Subjects must have one eye that with a diagnosis of infectious keratitis.

Exclusion criteria

  • A corneal perforation.
  • Descemetocele.
  • Pregnancy or breastfeeding.
  • Active Herpes corneal disease.
  • Patient is unwilling or unable to comply with a medication regimen and follow up appointments.

Treatment and study plan

Ultraviolet-A and riboflavin

Other

Primary outcomes

  1. Resolution of Signs and Symptoms of Infectious Keratitis

    Time frame: Subjects will be followed until resolution of signs and symptoms, an expected average of 8 weeks

Sponsors and collaborators

Lead sponsor

Cxlusa

Industry

Registry information

Important dates

Study start
2011
Primary completion
2014
Study completion
2014
First posted
Dec 3, 2012
Registry last updated
Sep 26, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.